Palliative therapy for osteosarcoma

Expert Review of Anticancer Therapy

Volumn 11, Issue 2, 2011, Pages 217-227

  Errani, Costantino ^a   Longhi, Alessandra ^a   Rossi, Giuseppe ^a   Rimondi, Eugenio ^a   Biazzo, Alessio ^a   Toscano, Angelo ^a   Alì, Nikolin ^a   Ruggieri, Pietro ^a   Alberghini, Marco ^a   Picci, Piero ^a   Bacci, Gaetano ^a   Mercuri, Mario ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

bone tumors; chemotherapy; embolization; osteosarcoma; palliation; radiotherapy; surgery; thermal ablation

Indexed keywords

ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CISPLATIN; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; LIPOSOMAL MURAMYL TRIPEPTIDE PHOSPHATIDYL ETHANOLAMINE; METHOTREXATE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; BONE CANCER; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CRYOTHERAPY; DRUG EFFECT; DRUG SAFETY; HUMAN; LOW DRUG DOSE; LUNG BIOPSY; LUNG LOBECTOMY; LUNG METASTASIS; LUNG NODULE; LUNG RESECTION; METASTATIC OSTEOSARCOMA; OSTEOLYSIS; OSTEOPOROSIS; OSTEOSARCOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PAGET BONE DISEASE; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; RECURRENT CANCER; REVIEW; THORACOTOMY; VIDEO ASSISTED THORACOSCOPIC SURGERY;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIMB SALVAGE; LUNG NEOPLASMS; MALE; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; OSTEOSARCOMA; PALLIATIVE CARE;

EID: 79952165556     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.10.172     Document Type: Review

References (64)

1. Wu PK, Chen WM, Chen CF, Lee OK, Haung CK, Chen TH. Primary osteogenic sarcoma with pulmonary metastasis: clinical results and prognostic factors in 91 patients. Jpn. J. Clin. Oncol. 39(8), 514-522 (2009).
2. Campanacci M. Bone and Soft Tissue Tumors (Second Edition). Springer, NY, USA (1999).
3. Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat. Res. 152, 3-13 (2010).
4. Ottaviani G, Jaffe N. The etiology of osteosarcoma. Cancer Treat. Res. 152, 15-32 (2010).
5. Gorlick R, Khanna C. Osteosarcoma. J. Bone Miner. Res. 25(4), 683-691 (2010).
6. Longhi A, Errani C, De Paolis M, Mercuri M, Bacci G. Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat. Rev. 32(6), 423-436 (2006).
7. Bacci G, Briccoli A, Longhi A et al. Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy. Acta Oncol. 44(7), 748-755 (2005). Retrospective review of 235 patients with osteosarcoma of the extremity who relapsed after neoadjuvant treatments performed between 1986 and 1998 at a single institution is reported.
8. Jaffe N, Bruland OS, Bielack SS. Pediatric and Adolescent Osteosarcoma. Springer, NY, USA (2009).
9. Merimsky O, Kollender Y, Inbar M, Meller I, Bickels J. Palliative treatment for advanced or metastatic osteosarcoma. Isr. Med. Assoc. J. 6(1), 34-38 (2004).
10. Bacci G, Rocca M, Salone M et al. High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions. J. Surg. Oncol. 98(6), 415-420 (2008). Retrospective review of 162 patients with extremity osteosarcoma and lung metastases at presentation treated by neoadjuvant chemotherapy, simultaneous resection of primary and, when feasible, secondary lesions followed by chemotherapy.
11. Kempf-Bielack B, Bielack SS, Jürgens H et al. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J. Clin. Oncol. 23(3), 559-568 (2005). Large retrospective analysis performed in order to evaluate the impact of patient, tumor and treatment-related factors on outcome in unselected patients with recurrent osteosarcoma.
12. Mialou V, Philip T, Kalifa C et al. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome - the French pediatric experience. Cancer 104(5), 1100-1109 (2005).
13. Federman N, Bernthal N, Eilber FC, Tap WD. The multidisciplinary management of osteosarcoma. Curr. Treat. Options Oncol. 10(1-2), 82-93 (2009).
14. Daw NC, Billups CA, Rodriguez-Galindo C et al. Metastatic osteosarcoma. Cancer 106(2), 403-412 (2006).
15. Briccoli A, Rocca M, Salone M, Guzzardella GA, Balladelli A, Bacci G. High grade osteosarcoma of the extremities metastatic to the lung: long-term results in 323 patients treated combining surgery and chemotherapy, 1985-2005. Surg. Oncol. 19(4), 193-199 (2009).
16. Ta HT, Dass CR, Choong PF, Dunstan DE. Osteosarcoma treatment: state of the art. Cancer Metastasis Rev. 28(1-2), 247-263 (2009).
17. Ferrari S, Briccoli A, Mercuri M et al. Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival. J. Clin. Oncol. 21(4), 710-715 (2003).
18. Ferrari S, Palmerini E. Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma. Curr. Opin. Oncol. 19(4), 341-346 (2007).
19. Bacci G, Longhi A, Fagioli F, Briccoli A, Versari M, Picci P. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy. Eur. J. Cancer 41(18), 2836-2845 (2005).
20. Kebudi R, Görgün O, Ayan I. Oral etoposide for recurrent/progressive sarcomas of childhood. Pediatr. Blood Cancer 42(4), 320-324 (2004).
21. Hansen MF, Seton M, Merchant A. Osteosarcoma in Paget's disease of bone. J. Bone Miner. Res. 21(Suppl. 2), P58-P63 (2006).
22. Shaylor PJ, Peake D, Grimer RJ, Carter SR, Tillman RM, Spooner D. Paget's osteosarcoma - no cure in sight. Sarcoma 3(3-4), 191-192 (1999).
23. Longhi A, Errani C, Gonzales-Arabio D, Ferrari C, Mercuri M. Osteosarcoma in patients older than 65 years. J. Clin. Oncol. 26(33), 5368-5373 (2008).
24. Murayama T, Kawasoe Y, Yamashita Y et al. Efficacy of the third-generation bisphosphonate risedronate alone and in combination with anticancer drugs against osteosarcoma cell lines. Anticancer Res. 28(4B), 2147-2154 (2008).
25. Anderson P. Liposomal muramyl tripeptide phosphatidyl ethanolamine: ifosfamide-containing chemotherapy in osteosarcoma. Future Oncol. 2(3), 333-343 (2006).
26. Picci P. Osteosarcoma (osteogenic sarcoma). Orphanet. J. Rare Dis. 2, 6 (2007).
27. Springfield D. Surgery for Bone and Soft-Tissue Tumors. Lippincott-Raven, PA, USA (1998).
28. Sampo MM, Tarkkanen M, Kivioja AH, Taskinen MH, Sankila R, Böhling TO. Osteosarcoma in Finland from 1971 through 1990: a nationwide study of epidemiology and outcome. Acta Orthop. 79(6), 861-866 (2008).
29. Fuchs B, Hoekzema N, Larson DR, Inwards CY, Sim FH. Osteosarcoma of the pelvis: outcome analysis of surgical treatment. Clin. Orthop. Relat. Res. 467(2), 510-518 (2009).
30. Cerfolio RJ, McCarty T, Bryant AS. Non-imaged pulmonary nodules discovered during thoracotomy for metastasectomy by lung palpation. Eur. J. Cardiothorac Surg. 35(5), 786-791; discussion 791 (2009).
31. Bacci G, Longhi A, Bertoni F et al. Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy: the Rizzoli experience in 52 patients. Acta Orthop. 77(6), 938-943 (2006). Retrospective review of 52 patients who had their first skeletal relapse after treatment for osteosarcoma of the extremity.
32. Aung L, Gorlick R, Healey JH et al. Metachronous skeletal osteosarcoma in patients treated with adjuvant and neoadjuvant chemotherapy for nonmetastatic osteosarcoma. J. Clin. Oncol. 21(2), 342-348 (2003).
33. San-Julian M, Diaz-de-Rada P, Noain E, Sierrasesumaga L. Bone metastases from osteosarcoma. Int. Orthop. 27(2), 117-120 (2003).
34. Bacci G, Longhi A, Cesari M, Versari M, Bertoni F. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients. Cancer 106(12), 2701-2706 (2006).
35. Grimer RJ, Sommerville S, Warnock D et al. Management and outcome after local recurrence of osteosarcoma. Eur. J. Cancer 41(4), 578-583 (2005). Retrospective review of 96 patients with nonmetastatic osteosarcoma who developed a local recurrence.
36. Nathan SS, Gorlick R, Bukata S et al. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis. Cancer 107(7), 1607-1616 (2006).
37. 153Sm-EDTMP in patients with poor-prognosis osteosarcoma. Cancer 115(11), 2514-2522 (2009). Retrospective review of 13 patients with recurrent or refractory osteosarcoma with bone metastases treated using Samarium-153 ethylene diamine tetramethylene phosphonate.
38. Hundsdoerfer P, Albrecht M, Rühl U, Fengler R, Kulozik AE, Henze G. Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma. Eur. J. Cancer 45(14), 2447-2451 (2009). Retrospective review of intensive local radiation therapy for a group of 13 patients with high-grade osteosarcoma in whom definitive surgery was not feasible or refused.
39. Anderson P, Aguilera D, Pearson M, Woo S. Outpatient chemotherapy plus radiotherapy in sarcomas: improving cancer control with radiosensitizing agents. Cancer Cont. 15(1), 38-46 (2008). Retrospective review of 39 high-risk osteosarcoma patients treated using multimodality therapy, including chemotherapy with radiation.
40. Blattmann C, Oertel S, Schulz-Ertner D et al. Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma. BMC Cancer 10, 96 (2010).
41. Mahajan A, Woo SY, Kornguth DG et al. Multimodality treatment of osteosarcoma: radiation in a high-risk cohort. Pediatr. Blood Cancer 50(5), 976-982 (2008).
42. Whelan JS, Burcombe RJ, Janinis J, Baldelli AM, Cassoni AM. A systematic review of the role of pulmonary irradiation in the management of primary bone tumours. Ann. Oncol. 13(1), 23-30 (2002).
43. Tan ML, Choong PF, Dass CR. Osteosarcoma: conventional treatment vs. gene therapy. Cancer Biol. Ther. 8(2), 106-117 (2009).
44. 153Sm-EDTMP), skeletal radiation for osteoblastic bone metastases and osteosarcoma. Expert Rev. Anticancer Ther. 7(11), 1517-1527 (2007).
45. DeLaney TF, Liebsch NJ, Pedlow FX et al. Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas. Int. J. Radiat. Oncol. Biol. Phys. 74(3), 732-739 (2009).
46. Krauel L, Albert A, Mora J et al. Use of angioembolization as an effective technique for the management of pediatric solid tumors. J. Pediatr. Surg. 44(9), 1848-1855 (2009).
47. Owen RJ. Embolization of musculoskeletal tumors. Radiol. Clin. North Am. 46(3), 535-543, vi (2008).
48. Gottfried ON, Schloesser PE, Schmidt MH, Stevens EA. Embolization of metastatic spinal tumors. Neurosurg. Clin. N. Am. 15(4), 391-399 (2004).
49. Kato Y, Tsuyuki A, Kikuchi K et al. Dramatic relief of pain by transcatheter arterial embolization for bone metastasis from hepatocellular carcinoma. J. Gastroenterol. Hepatol. 20(2), 326-327 (2005).
50. Börüban S, Sancak T, Yildiz Y, Saglik Y. Embolization of benign and malignant bone and soft tissue tumors of the extremities. Diagn. Interv. Radiol. 13(3), 164-171 (2007).
51. Chu JP, Chen W, Li JP et al. Clinicopathologic features and results of transcatheter arterial chemoembolization for osteosarcoma. Cardiovasc. Intervent. Radiol. 30(2), 201-206 (2007).
52. Zhang HJ, Yang JJ, Lu JP et al. Use of intra-arterial chemotherapy and embolization before limb salvage surgery for osteosarcoma of the lower extremity. Cardiovasc. Intervent. Radiol. 32(4), 672-678 (2009).
53. Thanos L, Mylona S, Galani P et al. Radiofrequency ablation of osseous metastases for the palliation of pain. Skeletal Radiol. 37(3), 189-194 (2008).
54. Nakamura T, Matsumine A, Yamakado K et al. Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas Cancer 115(16), 3774-3781 (2009).
55. Jones RL, McCall J, Adam A et al. Radiofrequency ablation is a feasible therapeutic option in the multi modality management of sarcoma. Eur. J. Surg. Oncol. 36(5), 477-482 (2010).
56. Ding JH, Chua TC, Glenn D, Morris DL. Feasibility of ablation as an alternative to surgical metastasectomy in patients with unresectable sarcoma pulmonary metastases. Interact. Cardiovasc. Thorac. Surg. 9(6), 1051-1053 (2009).
57. Callstrom MR, Atwell TD, Charboneau JW et al. Painful metastases involving bone: percutaneous image-guided cryoablation - prospective trial interim analysis. Radiology 241(2), 572-580 (2006). Retrospective review of 14 patients with bone metastases treated by cryoablation.
58. Callstrom MR, Kurup AN. Percutaneous ablation for bone and soft tissue metastases - why cryoablation? Skeletal Radiol. 38(9), 835-839 (2009).
59. Ward E, Munk PL, Rashid F, Torreggiani WC. Musculoskeletal interventional radiology: radiofrequency ablation. Radiol. Clin. North Am. 46(3), 599-610, vi-vii (2008).
60. Callstrom MR, Charboneau JW. Image-guided palliation of painful metastases using percutaneous ablation. Tech. Vasc. Interv. Radiol. 10(2), 120-131 (2007).
61. Gillams AR. Image guided tumour ablation. Cancer Imag. 5, 103-109 (2005).
62. Rybak LD. Fire and ice: thermal ablation of musculoskeletal tumors. Radiol. Clin. North Am. 47(3), 455-469 (2009).
63. Liapi E, Geschwind JF. Transcatheter and ablative therapeutic approaches for solid malignancies. J. Clin. Oncol. 25(8), 978-986 (2007).
64. Callstrom MR, Charboneau JW, Goetz MP et al. Image-guided ablation of painful metastatic bone tumors: a new and effective approach to a difficult problem. Skeletal Radiol. 35(1), 1-15 (2006).